Actin review
Every commitment length is printed on the product page, and the rate is stated flat at every dose.
The verdict
Actin prints three rates for compounded semaglutide on one page, read August 2026. They are $169 month to month, $143 on three months and $116 on six. Tirzepatide runs $269, $209 and $166. Both lines state the rate is flat at every dose.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- $116/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Actin sells both molecules by injection. Two lines carry figures. Each publishes three commitment lengths on the product page rather than at checkout.
Who writes the prescription, and what do they see?
A prescription precedes shipping. The product page carries rates and dose behavior rather than clinician detail. The intake is not documented.
Two disclosures do the work. Every cadence is on the page a reader lands on. And the flat-rate statement applies to all three. Most sellers publish one of those. Few publish both.
What happens when the dose goes up?
Actin states the rate holds at every dose, on both molecules. That claim is what makes the six-month figure meaningful. A rate that re-set at each step would make $116 an opening number rather than a rate.
What the price includes
$116 a month is the six-month rate. Month to month is $169. The commitment saves $53 a month, which is 31 percent. On tirzepatide the saving is $103, or 38 percent. Both ladders are steeper than most. Nothing is hidden behind an intake.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: All three cadences printed on the page
- Strength: Flat rate stated on both molecules
- Strength: The commitment discount is unusually steep
- Limitation: The low rate requires six months
- Limitation: No oral line is offered
- Limitation: No pharmacy is named
- Limitation: No state coverage list is recorded
What the evidence says about this kind of treatment
The assessment above is about Actin. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader comparing commitment lengths who wants the rate pinned across a titration.
- Wrong for
- A reader who wants a tablet, or who cannot commit past a month.
How Actin compares
| Seller | Who it suits | Go |
|---|---|---|
| AlyveRx | Readers who want a needle-free route named as such rather than implied | See AlyveRx → |
 Trimi Health | A reader who can pay a year at once, or finance it, and wants the per-month figure to stop moving as the dose rises. | See Trimi Health → |
| Lean Meds | A reader deciding between paying month to month and committing a year up front, because both rungs are published side by side. | See Lean Meds → |
More GLP-1 telehealth sellers reviews: Breeze MedsCare Bare RxCoreAge RxStrut HealthSynergy RxAgelessRx
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- What does the six-month plan save?
- $53 a month on semaglutide and $103 on tirzepatide, against the month-to-month rates. Both are printed on the product page.
- Does the rate change as the dose rises?
- Actin states it does not, on both molecules. That is what makes the longer-plan figure a rate rather than an opening number.
- Is there a tablet?
- No. Both lines are weekly injections.
- Is Actin expensive compared with other GLP-1 telehealth sellers?
- Actin publishes a starting figure of $169/mo. Across the 112 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $179, which puts Actin below the median, toward the cheaper end. The other 8 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.